|
US6726918B1
(en)
|
2000-07-05 |
2004-04-27 |
Oculex Pharmaceuticals, Inc. |
Methods for treating inflammation-mediated conditions of the eye
|
|
US6699493B2
(en)
|
2000-11-29 |
2004-03-02 |
Oculex Pharmaceuticals, Inc. |
Method for reducing or preventing transplant rejection in the eye and intraocular implants for use therefor
|
|
US7431710B2
(en)
|
2002-04-08 |
2008-10-07 |
Glaukos Corporation |
Ocular implants with anchors and methods thereof
|
|
US20050048099A1
(en)
|
2003-01-09 |
2005-03-03 |
Allergan, Inc. |
Ocular implant made by a double extrusion process
|
|
US8529927B2
(en)
*
|
2004-04-30 |
2013-09-10 |
Allergan, Inc. |
Alpha-2 agonist polymeric drug delivery systems
|
|
US7799336B2
(en)
|
2004-04-30 |
2010-09-21 |
Allergan, Inc. |
Hypotensive lipid-containing biodegradable intraocular implants and related methods
|
|
US8722097B2
(en)
|
2004-04-30 |
2014-05-13 |
Allergan, Inc. |
Oil-in-water method for making polymeric implants containing a hypotensive lipid
|
|
US20050244469A1
(en)
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Extended therapeutic effect ocular implant treatments
|
|
US7993634B2
(en)
|
2004-04-30 |
2011-08-09 |
Allergan, Inc. |
Oil-in-oil emulsified polymeric implants containing a hypotensive lipid and related methods
|
|
US8673341B2
(en)
|
2004-04-30 |
2014-03-18 |
Allergan, Inc. |
Intraocular pressure reduction with intracameral bimatoprost implants
|
|
US8685435B2
(en)
|
2004-04-30 |
2014-04-01 |
Allergan, Inc. |
Extended release biodegradable ocular implants
|
|
US9498457B2
(en)
|
2004-04-30 |
2016-11-22 |
Allergan, Inc. |
Hypotensive prostamide-containing biodegradable intraocular implants and related implants
|
|
ES2432556T3
(es)
|
2004-08-04 |
2013-12-04 |
Evonik Corporation |
Métodos para fabricar dispositivos de suministro y sus dispositivos
|
|
AU2014201844B2
(en)
*
|
2004-08-13 |
2016-06-16 |
Allergan, Inc |
Ocular implant made by a double extrusion process
|
|
AU2012216644B2
(en)
*
|
2004-08-13 |
2014-04-10 |
Allergan, Inc. |
Ocular implant made by a double extrusion process
|
|
AU2016228285B2
(en)
*
|
2004-08-13 |
2018-06-28 |
Allergan, Inc. |
Ocular implant made by a double extrusion process
|
|
US7931909B2
(en)
*
|
2005-05-10 |
2011-04-26 |
Allergan, Inc. |
Ocular therapy using alpha-2 adrenergic receptor compounds having enhanced anterior clearance rates
|
|
JP5122460B2
(ja)
|
2005-09-16 |
2013-01-16 |
アラーガン、インコーポレイテッド |
治療薬の眼内輸送のための組成物および方法
|
|
WO2007038453A2
(en)
*
|
2005-09-26 |
2007-04-05 |
Advanced Ocular Systems Limited |
Use of an anti-vascular endothelial growth factor (vegf) agent to ameliorate inflammation
|
|
US8877229B2
(en)
*
|
2005-12-02 |
2014-11-04 |
Eyetech Inc. |
Controlled release microparticles
|
|
US20070202186A1
(en)
|
2006-02-22 |
2007-08-30 |
Iscience Interventional Corporation |
Apparatus and formulations for suprachoroidal drug delivery
|
|
KR101446813B1
(ko)
|
2006-04-06 |
2014-10-01 |
뉴파쎄 인크. |
도파민 연관된 상태의 치료를 위한 이식체
|
|
US20070260203A1
(en)
*
|
2006-05-04 |
2007-11-08 |
Allergan, Inc. |
Vasoactive agent intraocular implant
|
|
EP2051710B1
(en)
*
|
2006-08-07 |
2011-11-02 |
Bausch & Lomb Incorporated |
Compositions and methods for treating, reducing, ameliorating, or alleviating posterior-segment ophthalmic diseases
|
|
US20080089923A1
(en)
*
|
2006-09-29 |
2008-04-17 |
Burkstrand Michael J |
Biodegradable ocular implants and methods for treating ocular conditions
|
|
US20080103368A1
(en)
*
|
2006-10-17 |
2008-05-01 |
Ari Craine |
Methods, devices, and computer program products for detecting syndromes
|
|
US8039010B2
(en)
*
|
2006-11-03 |
2011-10-18 |
Allergan, Inc. |
Sustained release intraocular drug delivery systems comprising a water soluble therapeutic agent and a release modifier
|
|
US8969415B2
(en)
*
|
2006-12-01 |
2015-03-03 |
Allergan, Inc. |
Intraocular drug delivery systems
|
|
EP2139492A1
(en)
*
|
2007-03-30 |
2010-01-06 |
Fovea Pharmaceuticals SA |
Methods for treating neovascular ocular diseases
|
|
US8642067B2
(en)
|
2007-04-02 |
2014-02-04 |
Allergen, Inc. |
Methods and compositions for intraocular administration to treat ocular conditions
|
|
US20080317805A1
(en)
*
|
2007-06-19 |
2008-12-25 |
Mckay William F |
Locally administrated low doses of corticosteroids
|
|
US9125807B2
(en)
|
2007-07-09 |
2015-09-08 |
Incept Llc |
Adhesive hydrogels for ophthalmic drug delivery
|
|
US20170360609A9
(en)
|
2007-09-24 |
2017-12-21 |
Ivantis, Inc. |
Methods and devices for increasing aqueous humor outflow
|
|
EP2222281B1
(en)
|
2007-12-20 |
2018-12-05 |
Evonik Corporation |
Process for preparing microparticles having a low residual solvent volume
|
|
CA2717441A1
(en)
|
2008-03-05 |
2009-09-11 |
Ivantis, Inc. |
Methods and apparatus for treating glaucoma
|
|
US8889173B2
(en)
*
|
2008-04-18 |
2014-11-18 |
Warsaw Orthopedic, Inc. |
Alpha adrenergic receptor agonists for treatment of pain and/or inflammation
|
|
US9610243B2
(en)
|
2008-04-18 |
2017-04-04 |
Warsaw Orthopedic, Inc. |
Clonidine compounds in a biodegradable polymer
|
|
US8524267B2
(en)
*
|
2008-04-18 |
2013-09-03 |
Warsaw Orthopedic, Inc. |
Dexamethasone formulations in a biodegradable material
|
|
US8946277B2
(en)
*
|
2008-04-18 |
2015-02-03 |
Warsaw Orthopedic, Inc. |
Clonidine formulations in a biodegradable polymer carrier
|
|
USRE48948E1
(en)
|
2008-04-18 |
2022-03-01 |
Warsaw Orthopedic, Inc. |
Clonidine compounds in a biodegradable polymer
|
|
US8557273B2
(en)
*
|
2008-04-18 |
2013-10-15 |
Medtronic, Inc. |
Medical devices and methods including polymers having biologically active agents therein
|
|
US9877973B2
(en)
|
2008-05-12 |
2018-01-30 |
University Of Utah Research Foundation |
Intraocular drug delivery device and associated methods
|
|
US10588855B2
(en)
|
2008-05-12 |
2020-03-17 |
University Of Utah Research Foundation |
Intraocular drug delivery device and associated methods
|
|
JP5591226B2
(ja)
|
2008-05-12 |
2014-09-17 |
ユニバーシティ・オブ・ユタ・リサーチ・ファウンデイション |
眼内薬物送達装置および関連する方法
|
|
US9095404B2
(en)
|
2008-05-12 |
2015-08-04 |
University Of Utah Research Foundation |
Intraocular drug delivery device and associated methods
|
|
US10064819B2
(en)
|
2008-05-12 |
2018-09-04 |
University Of Utah Research Foundation |
Intraocular drug delivery device and associated methods
|
|
JP6223659B2
(ja)
|
2008-11-10 |
2017-11-01 |
アレクシオン ファーマシューティカルズ， インコーポレイテッド |
補体関連障害を処置するための方法および組成物
|
|
US20120232649A1
(en)
|
2008-11-20 |
2012-09-13 |
Insight Innovations, Llc |
Intraocular Lens Cell Migration Inhibition System
|
|
US9943402B2
(en)
|
2008-11-20 |
2018-04-17 |
Insight Innovations, Llc |
Micropatterned intraocular implant
|
|
US8551167B2
(en)
|
2008-11-20 |
2013-10-08 |
Insight Innovations, Llc |
Intraocular implant cell migration inhibition system
|
|
MX2011005272A
(es)
*
|
2008-11-20 |
2011-06-21 |
Insight Innovations Llc |
Sistema de implante intraocular biocompatible biodegradable.
|
|
CA2757037C
(en)
|
2009-01-29 |
2019-08-06 |
Forsight Vision4, Inc. |
Posterior segment drug delivery
|
|
US8623395B2
(en)
|
2010-01-29 |
2014-01-07 |
Forsight Vision4, Inc. |
Implantable therapeutic device
|
|
JP5890182B2
(ja)
|
2009-02-12 |
2016-03-22 |
インセプト エルエルシー |
ヒドロゲルプラグによる薬物送達
|
|
US9636255B2
(en)
|
2009-02-13 |
2017-05-02 |
Dose Medical Corporation |
Uveoscleral drug delivery implant and methods for implanting the same
|
|
MX2011008936A
(es)
|
2009-02-24 |
2011-09-21 |
Alexion Pharma Inc |
Anticuerpos que contienen peptidos terapeuticos mimeticos de tpo/epo.
|
|
US20100239632A1
(en)
|
2009-03-23 |
2010-09-23 |
Warsaw Orthopedic, Inc. |
Drug depots for treatment of pain and inflammation in sinus and nasal cavities or cardiac tissue
|
|
US20100278897A1
(en)
*
|
2009-05-01 |
2010-11-04 |
Allergan, Inc. |
Intraocular bioactive agent delivery system with molecular partitioning system
|
|
US10206813B2
(en)
|
2009-05-18 |
2019-02-19 |
Dose Medical Corporation |
Implants with controlled drug delivery features and methods of using same
|
|
US12478503B2
(en)
|
2009-05-18 |
2025-11-25 |
Glaukos Corporation |
Implants with controlled drug delivery features and methods of using same
|
|
JP5937004B2
(ja)
|
2009-05-18 |
2016-06-22 |
ドーズ メディカル コーポレーションＤｏｓｅ Ｍｅｄｉｃａｌ Ｃｏｒｐｏｒａｔｉｏｎ |
薬剤溶出眼内インプラント
|
|
US9067384B2
(en)
*
|
2009-06-10 |
2015-06-30 |
Ppg Industries Ohio, Inc. |
Microporous material having degradation properties and articles prepared therefrom
|
|
NZ597259A
(en)
|
2009-06-23 |
2014-04-30 |
Alexion Pharma Inc |
Bispecific antibodies that bind to complement proteins
|
|
JP5726186B2
(ja)
|
2009-07-09 |
2015-05-27 |
イバンティス インコーポレイテッド |
眼内インプラントを送出するための単オペレータデバイス
|
|
WO2011006113A1
(en)
|
2009-07-09 |
2011-01-13 |
Ivantis, Inc. |
Ocular implants and methods for delivering ocular implants into the eye
|
|
CA2774495C
(en)
*
|
2009-09-17 |
2017-09-26 |
Evonik Degussa Corporation |
Implant devices that differ by release profile and methods of making and using same
|
|
US20110159066A1
(en)
*
|
2009-11-02 |
2011-06-30 |
Sebree Terri B |
Methods For Treating Parkinson's Disease
|
|
NZ716349A
(en)
|
2009-11-09 |
2017-07-28 |
Allergan Inc |
Compositions and methods for stimulating hair growth
|
|
US8529492B2
(en)
|
2009-12-23 |
2013-09-10 |
Trascend Medical, Inc. |
Drug delivery devices and methods
|
|
US10166142B2
(en)
|
2010-01-29 |
2019-01-01 |
Forsight Vision4, Inc. |
Small molecule delivery with implantable therapeutic device
|
|
US8889193B2
(en)
|
2010-02-25 |
2014-11-18 |
The Johns Hopkins University |
Sustained delivery of therapeutic agents to an eye compartment
|
|
AU2011245117B2
(en)
|
2010-04-30 |
2015-03-12 |
Alexion Pharmaceuticals, Inc. |
Anti-C5a antibodies and methods for using the antibodies
|
|
BR112012033119A2
(pt)
|
2010-06-22 |
2016-10-25 |
Univ Colorado Regents |
anticorpos para o fragamento c3d do componente do complemento 3.
|
|
WO2012012541A2
(en)
|
2010-07-21 |
2012-01-26 |
Allergan, Inc. |
SUSTAINED RELEASE siRNA FOR OCULAR DRUG DELIVERY
|
|
PT2600812T
(pt)
|
2010-08-05 |
2021-11-09 |
Forsight Vision4 Inc |
Aparelho para tratar um olho
|
|
WO2012019136A2
(en)
|
2010-08-05 |
2012-02-09 |
Forsight Vision 4, Inc. |
Injector apparatus and method for drug delivery
|
|
EP2600876B1
(en)
|
2010-08-05 |
2015-04-29 |
Forsight Vision4, Inc. |
Combined drug delivery methods and apparatus
|
|
WO2012051575A2
(en)
|
2010-10-15 |
2012-04-19 |
Iscience Interventional Corporation |
Device for ocular access
|
|
WO2012068549A2
(en)
|
2010-11-19 |
2012-05-24 |
Forsight Vision4, Inc. |
Therapeutic agent formulations for implanted devices
|
|
US9668915B2
(en)
|
2010-11-24 |
2017-06-06 |
Dose Medical Corporation |
Drug eluting ocular implant
|
|
TW201244737A
(en)
|
2011-02-03 |
2012-11-16 |
Alexion Pharma Inc |
Use of an anti-CD200 antibody for prolonging the survival of allografts
|
|
US10245178B1
(en)
|
2011-06-07 |
2019-04-02 |
Glaukos Corporation |
Anterior chamber drug-eluting ocular implant
|
|
LT2717914T
(lt)
*
|
2011-06-10 |
2020-03-25 |
Ramscor, Inc. |
Sulėtinto atpalaidavimo kompozicijos, skirtos baltymų pateikimui į akį, ir jų paruošimo būdai
|
|
US8657776B2
(en)
|
2011-06-14 |
2014-02-25 |
Ivantis, Inc. |
Ocular implants for delivery into the eye
|
|
WO2013003620A2
(en)
|
2011-06-28 |
2013-01-03 |
Forsight Vision4, Inc. |
Diagnostic methods and apparatus
|
|
ES2864203T3
(es)
|
2011-09-16 |
2021-10-13 |
Forsight Vision4 Inc |
Aparato de intercambio de fluido
|
|
US10226417B2
(en)
|
2011-09-16 |
2019-03-12 |
Peter Jarrett |
Drug delivery systems and applications
|
|
US8663150B2
(en)
|
2011-12-19 |
2014-03-04 |
Ivantis, Inc. |
Delivering ocular implants into the eye
|
|
WO2013116061A1
(en)
|
2012-02-03 |
2013-08-08 |
Forsight Vision4, Inc. |
Insertion and removal methods and apparatus for therapeutic devices
|
|
HRP20181671T1
(hr)
|
2012-02-09 |
2018-12-14 |
Novus International, Inc. |
Heteroatom koji sadrži cikličke dimere
|
|
US9358156B2
(en)
|
2012-04-18 |
2016-06-07 |
Invantis, Inc. |
Ocular implants for delivery into an anterior chamber of the eye
|
|
PL2871973T3
(pl)
|
2012-07-12 |
2019-02-28 |
Novus International Inc. |
Kompozycje matrycy i warstwy do ochrony środków bioaktywnych
|
|
US10413620B2
(en)
|
2012-08-17 |
2019-09-17 |
The Regents Of The University Of Colorado, A Body Corporate |
Light-emitting versions of the monoclonal antibody to C3D (MAB 3D29) for imaging
|
|
JP2015535212A
(ja)
|
2012-08-17 |
2015-12-10 |
ザ・リージエンツ・オブ・ザ・ユニバーシテイ・オブ・コロラド、ア・ボデイー・コーポレイト |
補体活性化を検出するための組成物および方法
|
|
WO2014052518A1
(en)
|
2012-09-27 |
2014-04-03 |
Allergan, Inc. |
Biodegradable drug delivery systems for the sustained release of proteins
|
|
WO2014066658A1
(en)
*
|
2012-10-26 |
2014-05-01 |
Allergan, Inc. |
Ketorolac-containing sustained release drug delivery systems
|
|
WO2014066644A1
(en)
*
|
2012-10-26 |
2014-05-01 |
Allergan, Inc. |
Ketorolac-containing sustained release drug delivery systems
|
|
WO2014066653A1
(en)
*
|
2012-10-26 |
2014-05-01 |
Allergan, Inc. |
Ketorolac-containing sustained release intraocular drug delivery systems
|
|
AU2013342275B2
(en)
|
2012-11-08 |
2017-11-09 |
Clearside Biomedical, Inc. |
Methods and devices for the treatment of ocular diseases in human subjects
|
|
WO2014085450A1
(en)
|
2012-11-28 |
2014-06-05 |
Ivantis, Inc. |
Apparatus for delivering ocular implants into an anterior chamber of the eye
|
|
EP2956096A1
(en)
|
2013-02-15 |
2015-12-23 |
Allergan, Inc. |
Sustained drug delivery implant
|
|
EP2968113B8
(en)
|
2013-03-14 |
2020-10-28 |
Forsight Vision4, Inc. |
Systems for sustained intraocular delivery of low solubility compounds from a port delivery system implant
|
|
US10517759B2
(en)
|
2013-03-15 |
2019-12-31 |
Glaukos Corporation |
Glaucoma stent and methods thereof for glaucoma treatment
|
|
CN105246438B
(zh)
|
2013-03-28 |
2018-01-26 |
弗赛特影像4股份有限公司 |
用于输送治疗物质的眼科植入物
|
|
JP6505079B2
(ja)
|
2013-03-29 |
2019-04-24 |
アレクシオン ファーマシューティカルズ， インコーポレイテッド |
補体ｃ５を標的とする治療薬の血清半減期を増加させるための組成物及び方法
|
|
SG10201702674PA
(en)
|
2013-05-03 |
2017-06-29 |
Clearside Biomedical Inc |
Apparatus and methods for ocular injection
|
|
WO2014197317A1
(en)
|
2013-06-03 |
2014-12-11 |
Clearside Biomedical, Inc. |
Apparatus and methods for drug delivery using multiple reservoirs
|
|
AU2014306002B2
(en)
|
2013-08-07 |
2017-05-25 |
Alexion Pharmaceuticals, Inc. |
Atypical hemolytic uremic syndrome (aHUS) biomarker proteins
|
|
JP6543431B2
(ja)
*
|
2013-10-10 |
2019-07-10 |
ユニバーシティー オブ ユタ リサーチ ファウンデーションＵｎｉｖｅｒｓｉｔｙ ｏｆ Ｕｔａｈ Ｒｅｓｅａｒｃｈ Ｆｏｕｎｄａｔｉｏｎ |
眼内薬物送達デバイスおよび付随する方法
|
|
EP4046628A1
(en)
|
2013-10-31 |
2022-08-24 |
Allergan, Inc. |
Prostamide-containing intraocular implants and methods of use thereof
|
|
ES2869024T3
(es)
|
2013-11-08 |
2021-10-22 |
Hollister Inc |
Catéteres oleófilos lubricados
|
|
WO2015073895A1
(en)
*
|
2013-11-15 |
2015-05-21 |
Allergan, Inc. |
Methods of treatment of ocular conditions with a sustained drug delivery implant
|
|
NZ711451A
(en)
|
2014-03-07 |
2016-05-27 |
Alexion Pharma Inc |
Anti-c5 antibodies having improved pharmacokinetics
|
|
AU2015266850B2
(en)
|
2014-05-29 |
2019-12-05 |
Glaukos Corporation |
Implants with controlled drug delivery features and methods of using same
|
|
BR112016029864A2
(pt)
*
|
2014-06-17 |
2017-08-22 |
Clearside Biomedical Inc |
métodos e dispositivos para tratamento de desordens oculares posteriores.
|
|
WO2015196085A2
(en)
|
2014-06-20 |
2015-12-23 |
Clearside Biomedical, Inc. |
Variable diameter cannula and methods for controlling insertion depth for medicament delivery
|
|
US10709547B2
(en)
|
2014-07-14 |
2020-07-14 |
Ivantis, Inc. |
Ocular implant delivery system and method
|
|
MX384889B
(es)
|
2014-07-15 |
2025-03-14 |
Forsight Vision4 Inc |
Dispositivo y metodo de entrega de implante ocular.
|
|
KR20170040798A
(ko)
|
2014-08-08 |
2017-04-13 |
포사이트 비젼4, 인크. |
수용체 티로신 키나제 억제제의 안정한 가용성 제제 및 그의 제조 방법
|
|
CA2962251A1
(en)
|
2014-10-03 |
2016-04-07 |
Ntercept, Llc |
Compositions and methods for inhibiting the biological activity of soluble biomolecules
|
|
EP3217924B1
(en)
|
2014-11-10 |
2025-07-16 |
ForSight Vision4, Inc. |
Expandable drug delivery devices
|
|
FR3028410A1
(fr)
|
2014-11-18 |
2016-05-20 |
Pierre Coulon |
Implant capsulaire multifonctionnel
|
|
MX2017007873A
(es)
|
2014-12-15 |
2017-11-06 |
Univ Johns Hopkins |
Formulaciones de sunitinib y metodos para uso de las mismas en el tratamiento de trastornos oculares.
|
|
EP3250588A1
(en)
|
2015-01-29 |
2017-12-06 |
Board of Trustees of Michigan State University |
Cryptic polypeptides and uses thereof
|
|
HK1249460A1
(zh)
|
2015-03-06 |
2018-11-02 |
Aerie Pharmaceuticals, Inc. |
植入物施用器和植入物的施用方法
|
|
CA2979397A1
(en)
|
2015-03-12 |
2016-09-15 |
Board Of Trustees Of Michigan State University |
Compositions and methods for measuring c-peptide binding and diagnosing immune-mediated diseases
|
|
WO2016183183A1
(en)
|
2015-05-11 |
2016-11-17 |
The Johns Hopkins University |
Autoimmune antibodies for use in inhibiting cancer cell growth
|
|
WO2016183296A1
(en)
|
2015-05-12 |
2016-11-17 |
Incept, Llc |
Drug delivery from hydrogels
|
|
JP2018525078A
(ja)
|
2015-07-22 |
2018-09-06 |
インセプト・リミテッド・ライアビリティ・カンパニーＩｎｃｅｐｔ，Ｌｌｃ |
被覆された涙点プラグ
|
|
CN115337254A
(zh)
|
2015-07-23 |
2022-11-15 |
爱瑞制药公司 |
用于治疗眼病的玻璃体内药物递送系统
|
|
JP6837475B2
(ja)
|
2015-08-14 |
2021-03-03 |
イバンティス インコーポレイテッド |
圧力センサを備えた眼用インプラントおよび送達システム
|
|
WO2017040853A1
(en)
|
2015-09-02 |
2017-03-09 |
Glaukos Corporation |
Drug delivery implants with bi-directional delivery capacity
|
|
US11564833B2
(en)
|
2015-09-25 |
2023-01-31 |
Glaukos Corporation |
Punctal implants with controlled drug delivery features and methods of using same
|
|
GB201519811D0
(en)
*
|
2015-11-10 |
2015-12-23 |
Univ Belfast |
Ocular compositions
|
|
US10441548B2
(en)
|
2015-11-12 |
2019-10-15 |
Graybug Vision, Inc. |
Aggregating microparticles for medical therapy
|
|
KR20180084104A
(ko)
|
2015-11-20 |
2018-07-24 |
포사이트 비젼4, 인크. |
연장 방출 약물 전달 장치를 위한 다공성 구조물
|
|
US11938058B2
(en)
|
2015-12-15 |
2024-03-26 |
Alcon Inc. |
Ocular implant and delivery system
|
|
US10390901B2
(en)
|
2016-02-10 |
2019-08-27 |
Clearside Biomedical, Inc. |
Ocular injection kit, packaging, and methods of use
|
|
PT109154B
(pt)
*
|
2016-02-12 |
2019-11-05 |
Univ De Coimbra |
Tecnologia não-invasiva de inserto ocular para libertação controlada de fármacos
|
|
US11617680B2
(en)
|
2016-04-05 |
2023-04-04 |
Forsight Vision4, Inc. |
Implantable ocular drug delivery devices
|
|
WO2017176762A1
(en)
|
2016-04-06 |
2017-10-12 |
Nanotics, Llc |
Particles comprising subparticles or nucleic acid scaffolds
|
|
CA3022830A1
(en)
|
2016-04-20 |
2017-10-26 |
Harold Alexander Heitzmann |
Bioresorbable ocular drug delivery device
|
|
JP2019514581A
(ja)
|
2016-05-02 |
2019-06-06 |
クリアサイド バイオメディカル，インコーポレイテッド |
眼の薬物送達のためのシステムおよび方法
|
|
CA3024618A1
(en)
|
2016-05-27 |
2017-11-30 |
Alexion Pharmaceuticals, Inc. |
Methods for treatment of refractory generalized myasthenia gravis
|
|
US10973681B2
(en)
|
2016-08-12 |
2021-04-13 |
Clearside Biomedical, Inc. |
Devices and methods for adjusting the insertion depth of a needle for medicament delivery
|
|
AU2017321980B2
(en)
|
2016-09-02 |
2020-04-30 |
Alcon Inc. |
Implant applicators
|
|
MX2019011242A
(es)
|
2017-03-23 |
2020-01-21 |
Graybug Vision Inc |
Farmacos y composiciones para el tratamiento de trastornos oculares.
|
|
WO2018204515A1
(en)
|
2017-05-02 |
2018-11-08 |
Georgia Tech Research Corporation |
Targeted drug delivery methods using a microneedle
|
|
MX2019013363A
(es)
|
2017-05-10 |
2020-01-13 |
Graybug Vision Inc |
Microparticulas de liberacion extendida y suspensiones de las mismas para terapia medica.
|
|
CN110913809B
(zh)
|
2017-06-13 |
2023-10-03 |
英福卡斯公司 |
用于治疗青光眼的系统、方法和装置
|
|
WO2018236904A1
(en)
|
2017-06-19 |
2018-12-27 |
Surface Oncology, Inc. |
COMBINATION OF ANTI-CD47 ANTIBODIES AND CELL DEATH INDUCING AGENTS, AND USES THEREOF
|
|
SG10201913147WA
(en)
|
2017-07-11 |
2020-02-27 |
Compass Therapeutics Llc |
Agonist antibodies that bind human cd137 and uses thereof
|
|
ES2965486T3
(es)
|
2017-07-27 |
2024-04-15 |
Alexion Pharma Inc |
Formulaciones de anticuerpos anti-C5 de alta concentración
|
|
US10584306B2
(en)
|
2017-08-11 |
2020-03-10 |
Board Of Regents Of The University Of Oklahoma |
Surfactant microemulsions
|
|
WO2019036605A2
(en)
|
2017-08-17 |
2019-02-21 |
Massachusetts Institute Of Technology |
MULTIPLE SPECIFICITY BINDING AGENTS OF CXC CHEMOKINES AND USES THEREOF
|
|
CN111050786A
(zh)
|
2017-09-08 |
2020-04-21 |
百时美施贵宝公司 |
用于治疗非酒精性脂肪性肝炎(nash)的方法的修饰的成纤维细胞生长因子21(fgf-21)
|
|
WO2019067499A1
(en)
|
2017-09-27 |
2019-04-04 |
Alexion Pharmaceuticals, Inc. |
BIOMARKER SIGNATURE FOR PREDICTING A TUMOR RESPONSE TO ANTI-CD200 THERAPY
|
|
JP7518764B2
(ja)
|
2017-10-26 |
2024-07-18 |
アレクシオン ファーマシューティカルズ， インコーポレイテッド |
発作性夜間ヘモグロビン尿症（ＰＮＨ）および非典型溶血性尿毒症症候群（ａＨＵＳ）の処置のための抗Ｃ５抗体の投薬量および投与
|
|
US11718679B2
(en)
|
2017-10-31 |
2023-08-08 |
Compass Therapeutics Llc |
CD137 antibodies and PD-1 antagonists and uses thereof
|
|
EP3713961A2
(en)
|
2017-11-20 |
2020-09-30 |
Compass Therapeutics LLC |
Cd137 antibodies and tumor antigen-targeting antibodies and uses thereof
|
|
CN115607358A
(zh)
|
2017-11-21 |
2023-01-17 |
弗赛特影像4股份有限公司 |
用于可扩展端口递送系统的流体交换装置及使用方法
|
|
CN112351755A
(zh)
|
2018-02-22 |
2021-02-09 |
伊万提斯公司 |
眼部植入物和输送系统
|
|
CN113754768B
(zh)
|
2018-03-14 |
2023-01-06 |
表面肿瘤学公司 |
结合cd39的抗体及其用途
|
|
CN120463807A
(zh)
|
2018-03-22 |
2025-08-12 |
表面肿瘤学有限责任公司 |
抗il-27抗体及其用途
|
|
WO2019200357A1
(en)
|
2018-04-12 |
2019-10-17 |
Surface Oncology, Inc. |
Biomarker for cd47 targeting therapeutics and uses therefor
|
|
CN119286871A
(zh)
|
2018-04-19 |
2025-01-10 |
查美特制药公司 |
合成rig-i样受体激动剂
|
|
CN112384534A
(zh)
|
2018-05-21 |
2021-02-19 |
指南针制药有限责任公司 |
用于增强nk细胞对靶细胞的杀死的组合物和方法
|
|
WO2019226658A1
(en)
|
2018-05-21 |
2019-11-28 |
Compass Therapeutics Llc |
Multispecific antigen-binding compositions and methods of use
|
|
EP3802593B1
(en)
|
2018-05-31 |
2024-09-11 |
Alexion Pharmaceuticals, Inc. |
Dosage and administration of anti-c5 antibodies for treatment of paroxysmal nocturnal hemoglobinuria (pnh) in pediatric patients
|
|
EP3802603A1
(en)
|
2018-06-04 |
2021-04-14 |
Alexion Pharmaceuticals, Inc. |
Dosage and administration of anti-c5 antibodies for treatment of atypical hemolytic uremic syndrome (ahus) in pediatric patients
|
|
JP7538723B2
(ja)
|
2018-06-28 |
2024-08-22 |
アレクシオン ファーマシューティカルズ， インコーポレイテッド |
抗ｃ５抗体の産生方法
|
|
WO2020018715A1
(en)
|
2018-07-17 |
2020-01-23 |
Massachusetts Institute Of Technology |
Soluble multimeric immunoglobulin-scaffold based fusion proteins and uses thereof
|
|
WO2020033926A2
(en)
|
2018-08-09 |
2020-02-13 |
Compass Therapeutics Llc |
Antibodies that bind cd277 and uses thereof
|
|
WO2020033923A1
(en)
|
2018-08-09 |
2020-02-13 |
Compass Therapeutics Llc |
Antigen binding agents that bind cd277 and uses thereof
|
|
WO2020033925A2
(en)
|
2018-08-09 |
2020-02-13 |
Compass Therapeutics Llc |
Antibodies that bind cd277 and uses thereof
|
|
US12240893B2
(en)
|
2018-10-30 |
2025-03-04 |
Alexion Pharmaceuticals, Inc. |
Subcutaneous dosage and administration of anti-C5 antibodies for treatment of paroxysmal nocturnal hemoglobinuria (PNH)
|
|
EP3876924B1
(en)
|
2018-11-06 |
2026-08-05 |
Georgetown University |
Cck inhibitors for use in treating non-alcoholic steatohepatitis or hepatic fibrosis
|
|
JP7497351B2
(ja)
|
2018-11-13 |
2024-06-10 |
コンパス セラピューティクス リミテッド ライアビリティ カンパニー |
チェックポイント分子に対する多重特異性結合性構築物およびその使用
|
|
AU2019399474B2
(en)
|
2018-12-13 |
2026-07-30 |
Surface Oncology, LLC |
Anti-IL-27 antibodies and uses thereof
|
|
CN113301886A
(zh)
*
|
2018-12-21 |
2021-08-24 |
瑞瓦纳治疗有限公司 |
包被的眼部植入物
|
|
JP7539897B2
(ja)
|
2019-01-16 |
2024-08-26 |
コンパス セラピューティクス リミテッド ライアビリティ カンパニー |
ヒトｃｄ１３７に結合する抗体の製剤およびその使用
|
|
US12350317B2
(en)
|
2019-02-08 |
2025-07-08 |
The Uab Research Foundation |
Immunotherapy for the treatment and prevention of inflammatory bowel disease
|
|
EP3976106A4
(en)
*
|
2019-05-31 |
2023-01-11 |
DOSE Medical Corporation |
BIOERODABLE POLYESTER-POLYMER IMPLANTS AND ASSOCIATED METHODS OF USE
|
|
CA3144406A1
(en)
|
2019-06-27 |
2020-12-30 |
Layerbio, Inc. |
Ocular device delivery methods and systems
|
|
US12403291B2
(en)
*
|
2019-08-30 |
2025-09-02 |
Intersect Ent, Inc. |
Submucosal bioresorbable drug eluting platform
|
|
KR20220062500A
(ko)
|
2019-09-16 |
2022-05-17 |
서피스 온콜로지, 인크. |
항-cd39 항체 조성물 및 방법
|
|
CA3151078A1
(en)
|
2019-09-25 |
2021-04-01 |
Surface Oncology, Inc. |
Anti-il-27 antibodies and uses thereof
|
|
US20220356234A1
(en)
|
2019-10-02 |
2022-11-10 |
Alexion Pharmaceuticals, Inc. |
Complement inhibitors for treating drug-induced complement-mediated response
|
|
CA3155202A1
(en)
|
2019-10-23 |
2021-04-29 |
Arthur M. Krieg |
Synthetic rig-i-like receptor agonists
|
|
US11459389B2
(en)
|
2019-10-24 |
2022-10-04 |
Massachusetts Institute Of Technology |
Monoclonal antibodies that bind human CD161
|
|
US12275986B2
(en)
|
2020-01-06 |
2025-04-15 |
Duke University |
Biomarkers associated with checkpoint immune therapy and methods of using same
|
|
CN115066232B
(zh)
|
2020-02-06 |
2024-12-10 |
视尔普斯眼科公司 |
用于治疗眼病的组合物和方法
|
|
CA3171563A1
(en)
|
2020-03-25 |
2021-09-30 |
Charles D. Blizzard |
Ocular implant containing a tyrosine kinase inhibitor
|
|
US12084509B2
(en)
|
2020-04-30 |
2024-09-10 |
Duke University |
Gene signatures for monitoring acute rejection and methods of using same
|
|
CN115667925A
(zh)
|
2020-05-15 |
2023-01-31 |
阿雷克森制药公司 |
使用细胞外囊泡来检测补体激活的方法以及其用于评估和/或监测补体介导的疾病的治疗的用途
|
|
CN116194478A
(zh)
|
2020-06-24 |
2023-05-30 |
阿雷克森制药公司 |
皮下（sc）施用抗c5抗体治疗补体相关病症
|
|
JP7879845B2
(ja)
|
2020-07-21 |
2026-06-24 |
アラーガン、インコーポレイテッド |
プロスタミドが高充填された眼内インプラント
|
|
US12577621B2
(en)
|
2020-09-08 |
2026-03-17 |
Duke University |
LRRK2 mutations as biomarkers for the prediction of immune checkpoint response in cancer
|
|
WO2022150684A1
(en)
|
2021-01-11 |
2022-07-14 |
Ivantis, Inc. |
Systems and methods for viscoelastic delivery
|
|
AU2022270170A1
(en)
|
2021-05-07 |
2023-09-21 |
Surface Oncology, LLC |
Anti-il-27 antibodies and uses thereof
|
|
CA3220629A1
(en)
|
2021-05-28 |
2022-12-01 |
Tobin J. CAMMETT |
Methods for detecting cm-tma biomarkers
|
|
WO2022251710A2
(en)
|
2021-05-28 |
2022-12-01 |
Sight Sciences, Inc. |
Intraocular devices, systems, and methods
|
|
USD1033637S1
(en)
|
2022-01-24 |
2024-07-02 |
Forsight Vision4, Inc. |
Fluid exchange device
|
|
WO2023230116A1
(en)
|
2022-05-25 |
2023-11-30 |
Surface Oncology, Inc. |
Use of anti-il-27 antibodies
|
|
US20240026001A1
(en)
|
2022-05-25 |
2024-01-25 |
Surface Oncology, Inc. |
Use of anti-il-27 antibodies
|
|
JP2025525881A
(ja)
|
2022-08-16 |
2025-08-07 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
眼内使用するためのニンテダニブの医薬製剤
|
|
CA3266977A1
(en)
|
2022-09-06 |
2024-03-14 |
Alexion Pharmaceuticals, Inc. |
DIAGNOSTIC AND PROGNOSIS BIOMARKER PROFILES IN PATIENTS WITH HEMATOPOIETIC STEM CELL TRANSPLANT-ASSOCIATED THROMBOTIC MICROANGIOPATHY (HSCT-TMA)
|
|
WO2024086306A1
(en)
*
|
2022-10-19 |
2024-04-25 |
Vitakey Inc. |
Formulated food products
|
|
JP2026520094A
(ja)
|
2023-04-11 |
2026-06-22 |
オキュラ セラピューティクス，インコーポレイテッド |
アキシチニブ多形ｉｖを含む眼科インプラント
|
|
WO2024229369A2
(en)
|
2023-05-03 |
2024-11-07 |
Board Of Regents, The University Of Texas System |
Antibodies targeting human leukocyte antigen cathepsin g peptide complex
|
|
WO2024238421A1
(en)
|
2023-05-12 |
2024-11-21 |
Alexion Pharmaceuticals, Inc. |
Use of biomarkers for the identification and treatment of complement-mediated disorders
|
|
WO2024238422A1
(en)
|
2023-05-12 |
2024-11-21 |
Alexion Pharmaceuticals, Inc. |
Use of a panel of lectins for detection of complement biomarkers in urine extracellular vesicles
|
|
USD1137672S1
(en)
|
2024-08-27 |
2026-07-28 |
Glaukos Corporation |
Drug eluting ocular implant
|
|
WO2026055167A1
(en)
|
2024-09-05 |
2026-03-12 |
Surface Oncology, LLC |
Anti-il-27 antibodies and use of biomarkers in uses thereof
|
|
WO2026055168A1
(en)
|
2024-09-06 |
2026-03-12 |
Surface Oncology, LLC |
Anti-il-27 antibodies and uses and doses thereof
|
|
WO2026101890A1
(en)
|
2024-11-05 |
2026-05-15 |
Surface Oncology, LLC |
Combinations of anti-il-27 antibodies with toripalimab and bevacizumab
|
|
WO2026151679A1
(en)
|
2025-01-07 |
2026-07-16 |
Compass Therapeutics, Llc. |
Multispecific binding constructs targeting pd-1 and vegf and uses thereof
|